Fangzhou Li

2PUBLICATIONS
6CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jun 17, 2022
Aberrant MEK5 signalling promotes clear cell renal cell carcinoma development via mTOR activation.

Fangzhou Li, Xufeng Peng, Jiale Zhou

|Dec 25, 2019
Identification of Long Noncoding RNA APOC1P1 as an Oncogene in Clear Cell Renal Cell Carcinoma.

Chong Sun, Zhonghan Zhou, Haoqing Shi

Pageof 1